Advertisement

Association of Proteins Irreversibly Labeled by 3H-Flunitrazepam with Different Benzodiazepine Receptors

  • W. Sieghart
Conference paper
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 18)

Summary

Studies of the regional distribution of proteins irreversibly labeled by 3H-flunitrazepam indicate that the contribution of the individual proteins to total irreversible binding of 3H-flunitrazepam was different in different brain regions and varied independently from each other.

Study of the inhibition by Cl 218 872 of 3H-flunitrazepam binding to the individual benzodiazepine binding proteins in cerebellum and hippocampus revealed that inhibition by Cl 218 872 of total irreversible binding of 3H-flunitrazepam to proteins was closely similar to that of reversible binding to membranes. However, when inhibition by Cl 218 872 of 3H-flunitrazepam binding to individual benzodiazepine binding proteins was measured, it was found that this substance had different affinity for the various individual proteins.

The present results are consistent with the hypothesis that the protein P51 is associated with the BZ1-benzodiazepine receptor subtype and that the individual proteins irreversibly labeled by 3H-flunitrazepam are independent from each other and associated with different benzodiazepine receptors.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Braestrup, C., Nielsen, M.: 3H-propyl-ß-carboline-3-carboxylate as a selective radioligand for the BZ,-benzodiazepine receptor subclass. J. Neuro-chem. 37, 333–341 (1981).Google Scholar
  2. Klepner, C.A., Lippa, A. S., Benson, D. I., Sano, M. C., Beer, B.: Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacol. Biochem. Behavior 11, 457–462 (1979).CrossRefGoogle Scholar
  3. Lippa, A. S., Klepner, C.A., Benson, D. I., Critchett, D.J., Sano, M. C., Beer, B.: The role of GABA in mediating the anticonvulsant properties of benzodiazepines. Brain Res. Bull. 5, 861–865 (1980).CrossRefGoogle Scholar
  4. Möhler, H., Battersby, M. K., Richards, J. G.: Benzodiazepine receptor protein identified and visualized in brain tissue by a photoaffinity label. Proc. Natl. Acad. Sci. U.S.A. 77, 1666–1670 (1980).CrossRefPubMedCentralPubMedGoogle Scholar
  5. Sieghart, W, Karobath, M.: Molecular heterogeneity of benzodiazepine receptors. Nature (Lond.) 286, 285–287 (1980).CrossRefGoogle Scholar
  6. Sieghart, W., Mayer, A.: Postnatal development of proteins irreversibly labeled by 3H-flunitrazepam. Neurosci. Lett. 31, 71–74 (1982).CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 1983

Authors and Affiliations

  • W. Sieghart
    • 1
  1. 1.Division of Biochemical PsychiatryPsychiatrische UniversitätsklinikWienAustria

Personalised recommendations